Susquehanna International Group, LLP Pep Gen Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding PEPG
# of Institutions
59Shares Held
24.7MCall Options Held
0Put Options Held
15K-
Ra Capital Management, L.P. Boston, MA10.7MShares$26 Million0.66% of portfolio
-
Rtw Investments, LP New York, NY3.19MShares$7.76 Million0.2% of portfolio
-
Viking Global Investors LP1.48MShares$3.6 Million0.02% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.17MShares$2.85 Million0.19% of portfolio
-
Black Rock Inc. New York, NY1.04MShares$2.52 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $57.4M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...